The absence of human papillomavirus in esophageal squamous cell carcinoma in East China

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 4184-4193

  Teng, Haohua ^a   Li, Xiaojing ^a   Liu, Xiuping ^a   Wu, Jie ^b   Zhang, Jie ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Human papillomavirus; PCR; RBD

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADULT; AGED; BIOSYNTHESIS; CHINA; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHINA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 84906257036     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Wu M, Liu AM, Kampman E, Zhang ZF, Van'T VP, Wu DL, Wang PH, Yang J, Qin Y, Mu LN, Kok FJ and Zhao JK. Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer 2009; 124: 1907-1913.
3. Fan Y, Yuan JM, Wang R, Gao YT and Yu MC. Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study. Nutr Cancer 2008; 60: 354-363.
4. Syrjanen KJ. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch 1982; 52: 283-292.
5. Saegusa M, Hashimura M, Takano Y, Ohbu M and Okayasu I. Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in esophageal and gastric carcinomas in Japan. Mol Pathol 1997; 50: 101-104.
6. White RE, Mungatana C, Mutuma G, Robert ME, Daniel RW, Topazian MD and Shah KV. Absence of human papillomavirus in esophageal carcinomas from southwestern Kenya. Dis Esophagus 2005; 18: 28-30.
7. Talamini G, Capelli P, Zamboni G, Mastromauro M, Pasetto M, Castagnini A, Angelini G, Bassi C and Scarpa A. Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer 2000; 86: 874-878.
8. Awerkiew S, Bollschweiler E, Metzger R, Schneider PM, Holscher AH and Pfister H. Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Med Microbiol Immunol 2003; 192: 137-140.
9. Kamath AM, Wu TT, Heitmiller R, Daniel R and Shah KV. Investigation of the association of esophageal carcinoma with human papillomaviruses. Dis Esophagus 2000; 13: 122-124.
10. Lagergren J, Wang Z, Bergstrom R, Dillner J and Nyren O. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst 1999; 91: 156-162.
11. Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N and Das BC. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005; 218: 69-79.
12. Matsha T, Donninger H, Erasmus RT, Hendricks D, Stepien A and Parker MI. Expression of p53 and its homolog, p73, in HPV DNA positive esophageal squamous cell carcinomas. Virology 2007; 369: 182-190.
13. Morgan RJ, Perry AC, Newcomb PV, Hardwick RH and Alderson D. Human papillomavirus and esophageal squamous cell carcinoma in the UK. Eur J Surg Oncol 1997; 23: 513-517.
14. Castillo A, Aguayo F, Koriyama C, Torres M, Carrascal E, Corvalan A, Roblero JP, Naquira C, Palma M, Backhouse C, Argandona J, Itoh T, Shuyama K, Eizuru Y and Akiba S. Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol 2006; 12: 6188-6192.
15. Hasegawa M, Ohoka I, Yamazaki K, Hanami K, Sugano I, Nagao T, Asoh A, Wada N, Nagao K and Ishida Y. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol Int 2002; 52: 442-450.
16. Miyagi J, Tsuhako K, Kinjo T, Iwamasa T and Hirayasu T. Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 2000; 53: 676-684.
17. de Villiers EM, Lavergne D, Chang F, Syrjanen K, Tosi P, Cintorino M, Santopietro R and Syrjanen S. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer 1999; 81: 225-228.
18. Cao B, Tian X, Li Y, Jiang P, Ning T, Xing H, Zhao Y, Zhang C, Shi X, Chen D, Shen Y and Ke Y. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005; 26: 1280-1284.
19. Li T, Lu ZM, Chen KN, Guo M, Xing HP, Mei Q, Yang HH, Lechner JF and Ke Y. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 2001; 22: 929-934.
20. Ding GC, Ren JL, Chang FB, Li JL, Yuan L, Song X, Zhou SL, Guo T, Fan ZM, Zeng Y and Wang LD. Human papillomavirus DNA and P16 (INK4A) expression in concurrent esophageal and gastric cardia cancers. World J Gastroenterol 2010; 16: 5901-5906.
21. Gao GF, Roth MJ, Wei WQ, Abnet CC, Chen F, Lu N, Zhao FH, Li XQ, Wang GQ, Taylor PR, Pan QJ, Chen W, Dawsey SM and Qiao YL. No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer 2006; 119: 1354-1359.
22. Peixoto GD, Hsin LS, Snijders P, Wilmotte R, Herrero R, Lenoir G, Montesano R, Meijer CJ, Walboomers J and Hainaut P. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of esophageal cancer in a high-risk area of China. Cancer Lett 2001; 162: 231-235.
23. Lam KY, He D, Ma L, Zhang D, Ngan HY, Wan TS and Tsao SW. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Hum Pathol 1997; 28: 657-663.
24. He D, Zhang DK, Lam KY, Ma L, Ngan HY, Liu SS and Tsao SW. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 1997; 72: 959-964.
25. Hou R, Xu C, Zhang S, Wu M and Zhang W. Distribution of human papillomavirus genotype and cervical neoplasia among women with abnormal cytology in Beijing, China. Int J Gynaecol Obstet 2012; 119: 257-261.
26. Dijkstra MG, Heideman DA, de Roy SC, Rozendaal L, Berkhof J, van Krimpen K, van Groningen K, Snijders PJ, Meijer CJ and van Kemenade FJ. p16 (INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol 2010; 63: 972-977.
27. de Villiers EM, Fauquet C, Broker TR, Bernard HU and Zur HH. Classification of papillomaviruses. Virology 2004; 324: 17-27.
28. Millikan RC. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1994; 86: 392-393.
29. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S and Et A. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-964.
30. Tase T, Okagaki T, Clark BA, Twiggs LB, Ostrow RS and Faras AJ. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol 1989; 8: 8-17.
31. Paavonen J. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials. Curr Med Res Opin 2008; 24: 1623-1634.
32. Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JJ and Gao YT. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer 1999; 83: 435-440.
33. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
34. Zhang H, Jin Y, Chen X, Jin C, Law S, Tsao SW and Kwong YL. Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet 2006; 165: 25-35.
35. Sano T, Oyama T, Kashiwabara K, Fukuda T and Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741-1748.
36. Sayed K, Korourian S, Ellison DA, Kozlowski K, Talley L, Horn HV, Simpson P and Parham DM. Diagnosing cervical biopsies in adolescents: the use of p16 immunohistochemistry to improve reliability and reproducibility. J Low Genit Tract Dis 2007; 11: 141-146.
37. Carico E, Fulciniti F, Giovagnoli MR, Losito NS, Botti G, Benincasa G, Farnetano MG and Vecchione A. Adhesion molecules and p16 expression in endocervical adenocarcinoma. Virchows Arch 2009; 455: 245-251.
38. Koo CL, Kok LF, Lee MY, Wu TS, Cheng YW, Hsu JD, Ruan A, Chao KC and Han CP. Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. J Transl Med 2009; 7: 25.
39. Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K and Nakagawa K. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer Med 2013; 2: 933-941.
40. Salam I, Hussain S, Mir MM, Dar NA, Abdullah S, Siddiqi MA, Lone RA, Zargar SA, Sharma S, Hedau S, Basir SF, Bharti AC and Das BC. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Mol Cell Biochem 2009; 332: 51-58.
41. Riethdorf S, Neffen EF, Cviko A, Loning T, Crum CP and Riethdorf L. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004; 35: 1477-1483.
42. Lerma E, Esteller M, Herman JG and Prat J. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Hum Pathol 2002; 33: 1120-1125.
43. Milde-Langosch K, Hagen M, Bamberger AM and Loning T. Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer. Int J Gynecol Pathol 2003; 22: 168-174.
44. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O and O'Leary JJ. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003; 56: 56-63.
45. Mannweiler S, Sygulla S, Winter E and Regauer S. Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression. J Am Acad Dermatol 2013; 69: 73-81.
46. Perez C, Castillo M, Alemany L, Tous S, Klaustermeier J, de Sanjose S and Velasco J. Evaluation of p16 (INK4a) overexpression in a large series of cervical carcinomas: concordance with SPF10-LiPA25 PCR. Int J Gynecol Pathol 2014; 33: 74-82.